Current Problems in Cancer

Papers
(The TQCC of Current Problems in Cancer is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Title Page77
USPS statement59
Table of Contents54
Information for Readers41
Editorial: Special issue on rare cancers37
Information for Readers29
Patient attendance at molecular tumor board: A new means of shared decision making?28
Artificial intelligence-based pathological application to predict regional lymph node metastasis in Papillary Thyroid Cancer27
Prognostic risk stratification using C-reactive protein, albumin, and associated inflammatory biomarkers in patients with advanced cancer in palliative care25
A real-world, population-based study of the trends for incidence and prognosis in high-grade neuroendocrine tumor of cervix24
Table of Contents22
Changing trends in disease burden of lung cancer in China from 1990-2019 and following 15-year prediction21
Secondary myeloma in patients with chronic lymphoblastic leukemia: A case report and analysis of data from SEER database20
Mapping the intricacies of GLI1 in hedgehog signaling: A combined bioinformatics and clinical analysis in Head & Neck cancer in Western India19
5-Fluorouracil associated neurovascular toxicities18
Comprehensive Pan-Cancer Analysis of MTF2 Effects on Human Tumors17
Title Page16
Title Page15
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?14
The impact of performing gastric cancer surgery during holiday periods. A population-based study using Dutch upper gastrointestinal cancer audit (DUCA) data14
Table of Contents13
Fibrolamellar carcinoma: An entity all its own13
Information for Readers13
Efficacy of atezolizumab, bevacizumab, carboplatin, and paclitaxel for epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer after tyrosine kinase inhibitor failure13
Dosing immune-checkpoint inhibitors: Opportunities for the future12
Information for Readers12
Technological innovations enhancing palliative care in cancer: A new era of patient care in India12
Do the recorded cases of oral cancer correspond to the actual numbers in India: The necessity of properly designed screening and surveying initiatives12
Conditional survival for high-risk early-stage cervical cancer patients with lymph node metastasis after hysterectomy11
Rs2686344 and serum squamous cell carcinoma antigen could predict clinical efficacy of neoadjuvant chemotherapy for cervical cancer11
The current state of proton radiotherapy11
Long-term outcomes in patients with central and ultracentral non-small cell lung cancer treated with stereotactic body radiotherapy: single-institution experience11
Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features11
Four versus six cycles of platinum-based chemotherapy for advanced Urothelial carcinoma in the era of immune checkpoint inhibitors: A retrospective cohort study (FOCUS, KCSG-GU23-08)11
Title Page10
Primary and secondary prevention of cervical cancer among Italian AFAB transgender people10
Solitary bone plasmacytoma: Long-term clinical outcomes in a single center10
Risk factors for omental metastasis and the effect of omentectomy on survival in type 2 endometrial cancer patients9
Management of fertility preservation in young female patients with gastrointestinal cancer: A case series and systematic literature review9
The predictive value of hematological inflammatory markers for severe oral mucositis in patients with nasopharyngeal carcinoma during intensity-modulated radiation therapy: A retrospective cohort stud9
Imaging of colon and rectal cancer9
Imaging of breast cancer–beyond the basics8
Title Page8
Emerging immuno-oncology targets in Myelodysplastic Syndromes (MDS)8
Prognostic significance of SIRI in patients with late-stage lung adenocarcinoma receiving EGFR-TKI treatment8
Rare case of intramedullary spinal cord metastasis from nasopharyngeal carcinoma8
Barriers, blocks, and barricades: Disparities to access of palliative care in cancer care7
Title Page7
A novel model to predict the risk of hematological toxicity in lung adenocarcinoma patients with pemetrexed plus platinum chemotherapy based on real-world data7
Clinical features and prognostic impact of TCF3–PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China7
CAR T-cell therapy for B-cell lymphoma7
Title Page7
Recurrence of high-grade vaginal intraepithelial neoplasia after various treatments7
Dietary influence on cancer progression: Gut health and genomic profiles7
Information for Readers7
Focused review on nutritional status of patients with immunoglobulin light chain amyloidosis7
Combination of immunotherapy, radiotherapy and denosumab as the best approach even for NSCLC poor prognosis patients: a case report with strong response, prolonged survival and a review of literature7
Borderline tumours of ovary and fertility preservation–Outcomes from a tertiary care center in India7
Safety of immune checkpoint inhibitors in patients with preexisting autoimmune disorders7
Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report6
Survival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting6
Examining the Cultural Appropriateness of Advance Care Planning Tools for Adolescents and Young Adults With Cancer: An Example of Cross-Cultural Adaptation of the Voicing My CHOiCES Tool6
A Neoplastic Lesion in the Pineal Region6
Bone marrow involvement in breast cancer6
Adjuvant Treatment Following Irradical Resection of Stage I-III Non-small Cell Lung Cancer: A Population-based Study6
Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving Larotrectinib6
Current and emerging strategies for the management of advanced/metastatic lung neuroendocrine tumors6
Is Hypoglycemia Secondary to Metastatic Retroperitoneal Sarcoma - A Therapeutic Challenge? Case Report and Review of Literature5
Title Page5
Current landscape of targeted therapy in esophageal squamous cell carcinoma5
Information for Readers5
Capivasertib in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative advanced breast cancer5
Information for Readers5
Table of Contents5
Creating a culture for change: Lessons from behavioral economics and complexity science to increase serious illness conversations for patients with cancer5
Information for Readers5
Table of Contents5
Chordoma: Current status, problems, and future directions5
Thrombotic events in patients using cyclin dependent kinase 4/6 inhibitors, analysis of existing ambulatory risk assessment models and the potential influences of tumor specific risk factors5
Information for Readers5
Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies5
Case report: Delayed retinoblastoma relapse in a lymph node after 9 years of complete remission5
Metaplastic breast cancer: Experience with ifosfamide based chemotherapy5
Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative)5
0.25443506240845